Balanced news tone
News Sentiment
R1MD34 sentiment intelligence
ResMed Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
20 relevant articles
News tone and price action are not far from neutral.
83/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, -0.7% over four weeks, trend inactive, and near fair-value range.
ResMed chairman & CEO Michael Farrell sells $1.09m in company stock
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
83/100 classification
One-week reaction
0.0%
Price digesting
Trend fit
Trend inactive
-0.7% over four weeks
Fair value
-17.7%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
3
Neutral
16
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Investing.com
Direct company coverage
ResMed chairman & CEO Michael Farrell sells $1.09m in company stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 12:44
- Source
- Investing.com
GuruFocus
Direct company coverage
Is ResMed Inc (RMD) a Bargain After 6.3% Drop? GF Value Says Und
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 22:33
- Source
- GuruFocus
Investing.com
Direct company coverage
ResMed stock held at Hold by Needham as MatrixCare sale announced
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 15:34
- Source
- Investing.com
GuruFocus
Direct company coverage
ResMed Inc (RMD) Shares Surge 4.2% -- What GF Score of 90 Tells Investors
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- GuruFocus
GuruFocus
Direct company coverage
ResMed Inc (RMD) Stock Down 3.9% -- Now Undervalued? GF Score: 9
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- GuruFocus
Investing.com
Direct company coverage
Morgan Stanley downgrades ResMed stock rating on margin concerns
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 07:00
- Source
- Investing.com
Barchart.com
Direct company coverage
Is ResMed Stock Underperforming the Dow?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Barchart.com
GuruFocus
Direct company coverage
Resmed Inc at William Blair Growth Stock Conference Transcript
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- GuruFocus
GuruFocus
Direct company coverage
ResMed Inc (RMD) Stock Down 6.3% -- Now Undervalued? GF Score: 9
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- GuruFocus
Investing.com
Direct company coverage
ResMed stock hits 52-week low at $198.60 amid challenging year
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
Needham reiterates Hold on ResMed stock on Noctrix acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 May 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
ResMed chairman and CEO Michael Farrell sells $1 million in stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
RBC Capital raises ResMed stock price target to $321 on growth
- Tone
- Positive 82/100
- Event
- Analyst action
- Published
- 01 May 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
ResMed stock hits 52-week low at $205.86 amid market challenges
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
Wolfe Research cuts ResMed stock price target on growth outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 01 May 2026 07:00
- Source
- Investing.com
The Motley Fool
Direct company coverage
ResMed (RMD) Q3 2026 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- The Motley Fool
Investing.com
Direct company coverage
Earnings call transcript: ResMed Q3 2026 reports mixed results, stock steady
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
Morgan Stanley cuts ResMed stock price target on market competition
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 27 Apr 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
ResMed Inc stock hits 52-week low at 218.27 USD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
Resmed director Farrell sells $502k in stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Feb 2026 08:00
- Source
- Investing.com